|
|
| | MK 0431-d4 Basic information |
| Product Name: | MK 0431-d4 | | Synonyms: | 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine-d4 Phosphate;Januvia-d4;MK 0431-d4;Sitagliptin-d4 Phosphate;[2H4]-Sitagliptin Phosphate;Sitagliptin D4 phosphateQ: What is
Sitagliptin D4 phosphate Q: What is the CAS Number of
Sitagliptin D4 phosphate Q: What is the storage condition of
Sitagliptin D4 phosphate Q: What are the applications of
Sitagliptin D4 phosphate;D4-Sitagliptin Phosphate | | CAS: | 1432063-88-1 | | MF: | C16H18F6N5O5P | | MW: | 505.31 | | EINECS: | | | Product Categories: | Intermediates & Fine Chemicals;Isotope Labeled Compounds;Pharmaceuticals;Isotope Labelled Compounds | | Mol File: | 1432063-88-1.mol |  |
| | MK 0431-d4 Chemical Properties |
| Melting point | 193-195°C | | storage temp. | -20°C Freezer | | solubility | Methanol (Slightly, Heated, Sonicated), Water (Slightly, Sonicated) | | form | Solid | | color | White to Off-White |
| | MK 0431-d4 Usage And Synthesis |
| Chemical Properties | White Solid | | Uses | A trizolopyrazine dipeptidyl peptidase IV inhibitor. It has recently been approved for the therapy of type II diabetes. | | IC 50 | DPP-4 |
| | MK 0431-d4 Preparation Products And Raw materials |
|